BioMarin Announces Record Revenues in First Quarter 2022

Go back to BioMarin Announces Record Revenues in First Quarter 2022
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 65.68 +0.95 (1.47%)
Previous Close $64.73    52 Week High $108.96 
Open $65.32    52 Week Low $62.12 
Day High $66.21    P/E N/A 
Day Low $65.32    EPS $-1.27 
Volume 66,957